Literature DB >> 27572924

The blood pressure response to vasodilator stress does not provide independent prognostic information.

Eliana Reyes1, Fadi G Hage2,3.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27572924     DOI： 10.1007/s12350-016-0651-8

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  23 in total

1.  Heart rate response to regadenoson: Making the case for its value in clinical practice.

Authors:  Efstathia Andrikopoulou; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-08-27       Impact factor: 5.952

2.  The prognostic value of regadenoson stress: Has the case been made?

Authors:  Rami Doukky
Journal:  J Nucl Cardiol       Date:  2015-05-21       Impact factor: 5.952

3.  Exercise hypertension: an adverse prognosis?

Authors:  Ryan G Smith; Stanley A Rubin; Myrvin H Ellestad
Journal:  J Am Soc Hypertens       Date:  2009 Nov-Dec

4.  A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging.

Authors:  Fadi G Hage; Phillip Dean; Fahad Iqbal; Jaekyeong Heo; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2011-07-22       Impact factor: 5.952

5.  The prognostic value of regadenoson myocardial perfusion imaging.

Authors:  Fadi G Hage; Gopal Ghimire; Davis Lester; Joshua Mckay; Steven Bleich; Stephanie El-Hajj; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2015-02-14       Impact factor: 5.952

Review 6.  Exercise-induced hypertension, cardiovascular events, and mortality in patients undergoing exercise stress testing: a systematic review and meta-analysis.

Authors:  Martin G Schultz; Petr Otahal; Verity J Cleland; Leigh Blizzard; Thomas H Marwick; James E Sharman
Journal:  Am J Hypertens       Date:  2012-12-27       Impact factor: 2.689

7.  The relationship between ischemia-induced left ventricular dysfunction, coronary flow reserve, and coronary steal on regadenoson stress-gated (82)Rb PET myocardial perfusion imaging.

Authors:  Andrew Van Tosh; John R Votaw; Nathaniel Reichek; Christopher J Palestro; Kenneth J Nichols
Journal:  J Nucl Cardiol       Date:  2013-10-04       Impact factor: 5.952

8.  Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial.

Authors:  Ami E Iskandrian; Timothy M Bateman; Luiz Belardinelli; Brent Blackburn; Manuel D Cerqueira; Robert C Hendel; Hsiao Lieu; John J Mahmarian; Ann Olmsted; S Richard Underwood; João Vitola; Whedy Wang
Journal:  J Nucl Cardiol       Date:  2007 Sep-Oct       Impact factor: 5.952

9.  Comparative assessment of rest and post-stress left ventricular volumes and left ventricular ejection fraction on gated myocardial perfusion imaging (MPI) and echocardiography in patients with transient ischaemic dilation on adenosine MPI: myocardial stunning or subendocardial hypoperfusion?

Authors:  Louise Emmett; Austin Ng; Leo Ha; Robert Russo; Robert Mansberg; Wei Zhao; S Vincent Chow; Leonard Kritharides
Journal:  J Nucl Cardiol       Date:  2012-05-08       Impact factor: 5.952

10.  Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus.

Authors:  Fadi G Hage; Jaekyeong Heo; Billy Franks; Luiz Belardinelli; Brent Blackburn; Whedy Wang; Ami E Iskandrian
Journal:  Am Heart J       Date:  2009-03-06       Impact factor: 4.749
View more
  1 in total

Review 1.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology in 2017. Part 2 of 2: Myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2018-04-16       Impact factor: 5.952
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.